[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Sagnol
P
P
Hôpital Cardiologique, B.P. Lyon Montchat.
Delahaye
J P
JP
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D004176:Dipyridamole / Q000627:therapeutic use*; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D015201:Meta-Analysis as Topic; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013988:Ticlopidine / Q000627:therapeutic use; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014812:Vitamin K; D004176:Dipyridamole; D013988:Ticlopidine; D001241:Aspirin; D013442:Sulfinpyrazone
Traitement anticoagulant ou traitement anti-agrégant après pontage aorto-coronaire?